Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-17-002439
Filing Date
2017-03-09
Accepted
2017-03-09 17:11:48
Documents
56
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K imuc-123116x10k.htm 10-K 1382087
2 EXHIBIT 10.63 imuc-123116xexhibit1063.htm EX-10.63 93792
3 EXHIBIT 23.1 imuc-123116xexhibit231.htm EX-23.1 3137
4 EXHIBIT 31.1 imuc-123116xexhibit311.htm EX-31.1 12904
5 EXHIBIT 31.2 imuc-123116xexhibit312.htm EX-31.2 13196
6 EXHIBIT 32.1 imuc-123116xexhibit321.htm EX-32.1 7247
7 EXHIBIT 32.2 imuc-123116xexhibit322.htm EX-32.2 7159
  Complete submission text file 0001628280-17-002439.txt   4832706

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT imuc-20161231.xml EX-101.INS 628794
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imuc-20161231.xsd EX-101.SCH 36733
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imuc-20161231_cal.xml EX-101.CAL 52019
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imuc-20161231_def.xml EX-101.DEF 142885
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imuc-20161231_lab.xml EX-101.LAB 510068
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imuc-20161231_pre.xml EX-101.PRE 281368
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35560 | Film No.: 17679327
SIC: 2834 Pharmaceutical Preparations